T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Palantir
PLTR
$423B
| $137M | 0.02% |
5,426,912
-450,545
| -8% | -$10.1M |
|
477
Devon Energy
DVN
$48.2B
| $136M | 0.02% |
2,871,556
+1,950,971
| +212% | +$97M |
|
|
SWTX
478
DELISTED
SpringWorks Therapeutics
SWTX
| $136M | 0.02% |
3,602,234
-508,228
| -12% | -$21.4M |
|
479
TC Energy
TRP
$65.9B
| $136M | 0.02% |
3,577,237
+709,014
| +25% | +$26.9M |
|
480
Quanta Services
PWR
$102B
| $134M | 0.02% |
526,768
+3,028
| +0.6% | +$802K |
|
481
Johnson Controls International
JCI
$91.7B
| $134M | 0.02% |
2,013,087
+159,334
| +9% | +$10.7M |
|
482
Dell
DELL
$323B
| $133M | 0.02% |
967,965
+186,465
| +24% | +$25M |
|
483
News Corp Class B
NWS
$17.9B
| $133M | 0.02% |
4,690,713
-316,947
| -6% | -$8.43M |
|
484
Charles River Laboratories
CRL
$13.6B
| $132M | 0.02% |
640,985
-681,469
| -52% | -$154M |
|
485
Itaú Unibanco
ITUB
$81.8B
| $132M | 0.02% |
+25,601,601
| New | +$140M |
|
486
IDEAYA Biosciences
IDYA
$3.57B
| $131M | 0.02% |
3,743,741
-308,759
| -8% | -$12.2M |
|
487
Vera Therapeutics
VERA
$2.14B
| $131M | 0.02% |
3,620,135
+1,227,106
| +51% | +$48.7M |
|
488
Vistra
VST
$49.1B
| $131M | 0.02% |
1,518,133
+877,157
| +137% | +$73.4M |
|
489
Nutanix
NTNX
$17.7B
| $130M | 0.02% |
2,279,571
-2,079,197
| -48% | -$128M |
|
490
Ameriprise Financial
AMP
$49.9B
| $129M | 0.02% |
302,604
+89,971
| +42% | +$38.4M |
|
491
Hanover Insurance
THG
$7.76B
| $129M | 0.02% |
1,030,507
+65,269
| +7% | +$8.49M |
|
492
NetEase
NTES
$78.5B
| $128M | 0.02% |
1,340,555
+338,739
| +34% | +$32.2M |
|
493
Cytokinetics
CYTK
$10.5B
| $128M | 0.02% |
2,358,343
-572,605
| -20% | -$34.6M |
|
494
Leidos
LDOS
$17.7B
| $127M | 0.02% |
868,048
+350,550
| +68% | +$49M |
|
495
Coinbase
COIN
$39.9B
| $126M | 0.02% |
569,151
-405,392
| -42% | -$93.3M |
|
496
Zscaler
ZS
$29.3B
| $126M | 0.02% |
657,426
-216,267
| -25% | -$38.5M |
|
497
Petrobras
PBR
$114B
| $126M | 0.02% |
8,716,305
+7,891,928
| +957% | +$123M |
|
498
Veralto
VLTO
$23.6B
| $125M | 0.01% |
1,308,090
-791,935
| -38% | -$75.7M |
|
499
Duke Energy
DUK
$96.8B
| $124M | 0.01% |
1,233,538
+29,622
| +2% | +$2.96M |
|
500
State Street SPDR S&P Homebuilders ETF
XHB
$1.6B
| $124M | 0.01% |
1,222,090
+173,290
| +17% | +$18.1M |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.